Stock Volatility: Recent chatter on social media about Beyond Meat has centered on the dramatic ups and downs of its stock price. Many users are discussing a significant surge late last year, with some noting a staggering rise of over 1,000% in just days. However, the excitement is tempered by concerns over the stock now trading in penny stock territory.
Company Challenges: Discussions also highlight ongoing struggles, including leadership changes and financial reporting issues. Some express hope for a turnaround, pointing to restructuring efforts and rising meat prices as potential catalysts. Others remain skeptical, citing persistent liquidity concerns and legal setbacks as major hurdles.
Future Potential: A segment of the conversation focuses on long-term optimism, with users mentioning the growing interest in plant-based foods. There’s speculation about the stock rebounding significantly, though doubts linger about whether the company can overcome its current crises.
Note: This discussion summary was generated from an AI condensation of post data.
Beyond Meat Insider Trading Activity
Beyond Meat insiders have traded $BYND stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $BYND stock by insiders over the last 6 months:
- CHELSEA A GRAYSON has made 0 purchases and 6 sales selling 2,952 shares for an estimated $6,475.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Beyond Meat Revenue
Beyond Meat had revenues of $70.2M in Q3 2025. This is a decrease of -13.32% from the same period in the prior year.
You can track BYND financials on Quiver Quantitative's BYND stock page.
Beyond Meat Hedge Fund Activity
We have seen 81 institutional investors add shares of Beyond Meat stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 1,783,428 shares (+198.9%) to their portfolio in Q3 2025, for an estimated $3,370,678
- VONTOBEL HOLDING LTD. added 804,125 shares (+38.0%) to their portfolio in Q3 2025, for an estimated $1,519,796
- MIRAE ASSET SECURITIES (USA) INC. removed 723,125 shares (-94.3%) from their portfolio in Q3 2025, for an estimated $1,366,706
- SUSQUEHANNA PORTFOLIO STRATEGIES, LLC added 425,126 shares (+inf%) to their portfolio in Q3 2025, for an estimated $803,488
- GOLDMAN SACHS GROUP INC added 423,529 shares (+58.4%) to their portfolio in Q3 2025, for an estimated $800,469
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 372,576 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $704,168
- UBS GROUP AG added 274,026 shares (+27.7%) to their portfolio in Q3 2025, for an estimated $517,909
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Beyond Meat Analyst Ratings
Wall Street analysts have issued reports on $BYND in the last several months. We have seen 0 firms issue buy ratings on the stock, and 5 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Underperform" rating on 11/13/2025
- Barclays issued a "Underweight" rating on 11/12/2025
- TD Cowen issued a "Sell" rating on 10/14/2025
- Argus Research issued a "Sell" rating on 09/15/2025
- JP Morgan issued a "Underweight" rating on 08/20/2025
To track analyst ratings and price targets for Beyond Meat, check out Quiver Quantitative's $BYND forecast page.
Beyond Meat Price Targets
Multiple analysts have issued price targets for $BYND recently. We have seen 5 analysts offer price targets for $BYND in the last 6 months, with a median target of $1.0.
Here are some recent targets:
- John Baumgartner from Mizuho set a target price of $1.0 on 11/13/2025
- Benjamin Theurer from Barclays set a target price of $1.0 on 11/12/2025
- Robert Moskow from TD Cowen set a target price of $0.8 on 10/14/2025
- Peter Saleh from BTIG set a target price of $283.49 on 09/30/2025
- Andrew Strelzik from BMO Capital set a target price of $4.0 on 08/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
